Fraud case has hemp in the news, unfortunately

Analysis from HempToday, the voice of the global hemp industries.

With CBD maker CV Sciences (CVS) joining Hemp Inc. last month as the second target of a federal fraud case in the USA, the question resurfaces: How much damage to the industry’s image? Critics have long railed against the entire penny-stock empire-building “strategy” (see: “Wolf of Wall Street” and tack on the subheadline: “Hemp investing for suckers”).

You need to login to view the rest of the content. Please . Not a Member? Join Us